Vertellus, a manufacturer of specialty materials for various consumer goods, food, agriculture and healthcare markets, has acquired Jarchem Innovative Ingredients, a global manufacturer and supplier of unique specialty ingredients and nature-based products. 
 
With this acquisition, Vertellus expands its offering of environmentally friendly ingredients and serves a growing global base of customers in high-growth specialty, personal, home and health care markets. 
 
Jarchem has a leading portfolio of proprietary, nature-based products that are increasingly popular as consumers demand all-natural alternatives. Based in Newark, NJ, the company offers a range of alternatives for traditional esters, silicones and other products commonly used in personal care, food and specialty industrial markets, providing cleaner, greener formulations for its customers. Jarchem brings to Vertellus an expanded global base of long-standing customers and a long- tenured management team with substantial technical expertise. 
 
“Jarchem’s high-quality portfolio of nature-based ingredients and products is an exciting addition to Vertellus,” said John Van Hulle, CEO of Vertellus. “By extending our reach in high-growth specialty and personal care markets, together we will better serve our customers. We welcome the Jarchem team to the Vertellus family.” 
 
“The Jarchem team is thrilled to partner with Vertellus to bring our compelling product portfolio to more customers around the world,” said Art Hein, managing director of Jarchem. “As consumers increasingly seek natural, healthy alternatives to conventional products, together our companies are well-positioned for long-term growth.” 
 
“This acquisition extends Vertellus’ strategic priority to further strengthen its portfolio of innovative specialty ingredients,” added Thomas Chadwick, principal at Pritzker Private Capital, which, along with management, owns Indianapolis-based Vertellus.  “The combined company has an attractive position in high-growth markets and is poised for continued, long-term success.” 
 
Balmoral Advisors represented Jarchem on the transaction.